miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells

被引:96
作者
Jude, Joseph A. [1 ]
Dileepan, Mythili [1 ]
Subramanian, Subbaya [2 ]
Solway, Julian [3 ]
Panettieri, Reynold A., Jr. [4 ]
Walseth, Timothy F. [5 ]
Kannan, Mathur S. [1 ]
机构
[1] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN USA
[2] Univ Minnesota, Dept Surg, St Paul, MN USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[4] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Minnesota, Dept Pharmacol, St Paul, MN USA
基金
美国国家卫生研究院;
关键词
asthma; gene expression; microRNA; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ADP-RIBOSYL CYCLASE; MICRORNA EXPRESSION; RESPONSIVENESS; ACTIVATION; INDUCTION; PATHWAY;
D O I
10.1152/ajplung.00041.2012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Jude JA, Dileepan M, Subramanian S, Solway J, Panettieri RA Jr, Walseth TF, Kannan MS. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 303: L460-L468, 2012. First published July 6, 2012; doi:10.1152/ajplung.00041.2012.-CD38, a membrane protein expressed in airway smooth muscle (ASM) cells, plays a role in cellular Ca2+ dynamics and ASM contractility. In human ASM (HASM) cells, TNF-alpha induces CD38 expression through activation of MAPKs, NF-kappa B, and AP-1, and its expression is differentially elevated in cells from asthmatic patients compared with cells from nonasthmatic subjects. The CD38 3'-untranslated region (UTR) has targets for miR-140-3p. We hypothesized that miR-140-3p regulates CD38 expression in HASM cells by altering CD38 mRNA stability. Basal and TNF-alpha-induced expression of miR-140-3p was determined in nonasthmatic ASM (NAASM) and asthmatic ASM (AASM) cells. NAASM and AASM cells were transfected with control, miR-140-3p mimic, or miR-140-3p antagomirs, and CD38 expression and CD38 mRNA stability were determined. Luciferase reporter assays were used to determine miR-140-3p binding to the CD38 3'-UTR. Activation of p38, ERK, and JNK MAPKs, NF-kappa B, and AP-1 was determined in miR-140-3p mimic-transfected NAASM. TNF-alpha attenuated miR-140-3p expression in NAASM and AASM cells, but at a greater magnitude in AASM cells. CD38 mRNA expression was attenuated by miR-140-3p mimic at comparable magnitude in NAASM and AASM cells. Mutated miR-140-3p target on the CD38 3'-UTR reversed the inhibition of luciferase activity by miR-140-3p mimic. CD38 mRNA stability was unaltered by miR-140-3p mimic in NAASM or AASM cells following arrest of transcription. TNF-alpha-induced activation of p38 MAPK and NF-kappa B was attenuated by miR-140-3p mimic. The findings indicate that miR-140-3p modulates CD38 expression in HASM cells through direct binding to the CD38 3'-UTR and indirect mechanisms involving activation of p38 MAPK and NF-kappa B. Furthermore, indirect mechanisms appear to play a major role in the regulation of CD38 expression.
引用
收藏
页码:L460 / L468
页数:9
相关论文
共 34 条
[1]  
Albuquerque RV, 1998, CLIN EXP ALLERGY, V28, P578
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   Evidence of a role of tumor necrosis factor α in refractory asthma [J].
Berry, MA ;
Hargadon, B ;
Shelley, M ;
Parker, D ;
Shaw, DE ;
Green, RH ;
Bradding, P ;
Brightling, CE ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :697-708
[4]   INTERLEUKIN-4, INTERLEUKIN-5, AND INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA IN NORMAL AND ASTHMATIC AIRWAYS - EVIDENCE FOR THE HUMAN MAST-CELL AS A SOURCE OF THESE CYTOKINES [J].
BRADDING, P ;
ROBERTS, JA ;
BRITTEN, KM ;
MONTEFORT, S ;
DJUKANOVIC, R ;
MUELLER, R ;
HEUSSER, CH ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (05) :471-480
[5]   Down-Regulation of miR-133a Contributes to Up-Regulation of RhoA in Bronchial Smooth Muscle Cells [J].
Chiba, Yoshihiko ;
Tanabe, Miki ;
Goto, Kumiko ;
Sakai, Hiroyasu ;
Misawa, Miwa .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (08) :713-719
[6]   Altered airway responsiveness in CD38-deficient mice [J].
Deshpande, DA ;
White, TA ;
Guedes, AGP ;
Milla, C ;
Walseth, TF ;
Lund, FE ;
Kannan, MS .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 32 (02) :149-156
[7]   CD38-cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyperresponsiveness [J].
Deshpande, DA ;
Walseth, TF ;
Panettieri, RA ;
Kannan, MS .
FASEB JOURNAL, 2003, 17 (01) :452-+
[8]   Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma [J].
Desmet, C ;
Gosset, P ;
Pajak, B ;
Cataldo, D ;
Bentires-Alj, M ;
Lekeux, P ;
Bureau, F .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5766-5775
[9]   Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease [J].
Edwards, Michael R. ;
Bartlett, Nathan W. ;
Clarke, Deborah ;
Birrell, Mark ;
Belvisi, Maria ;
Johnston, Sebastian L. .
PHARMACOLOGY & THERAPEUTICS, 2009, 121 (01) :1-13
[10]   Role of CD38 in TNF-α-induced airway hyperresponsiveness [J].
Guedes, Alonso G. P. ;
Jude, Joseph A. ;
Paulin, Jaime ;
Kita, Hirohito ;
Lund, Frances E. ;
Kannan, Mathur S. .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 294 (02) :L290-L299